Pulse Biosciences, Inc.
PLSE· Nasdaq
PLSEPulse Biosciences, Inc.
Filed Mar 12, 2021 · 10-K · 71 days after period end · 0001625101-21-000014
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Net Income | -$13.75M | -$13.79M | -$8.95M | -$8.70M |
| EPS Diluted | — | -$0.66 | -$0.51 | -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 12, 2021 · 71 d after period end
